To this regard, a recently published pan-cancer bioinformatics analysis, integrating several parameters such as gene expression and regulation, prognosis, and mutations across multiple cancer types, has shown that high FANCD2 expression was associated with poor prognosis in certain tumors (Zhao et al., 2024). Here, FANCD2 is linked to cancer.